EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), TOP1 inhibitors(DNA topoisomerase I inhibitors), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors)

Therapeutic Areas

NeoplasmsDigestive System DisordersRespiratory Diseases

Active Indication

Colorectal CancerLiver CancerNon-Small Cell Lung Cancer+ [1]

Inactive Indication-

Originator Organization

Simcere Pharmaceutical Group Ltd.

Active Organization

Shang Hai Xian Wei Yi Yao Ke Ji You Xian Gong Si

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Structure/Sequence

Boost your research with our ADC technology data.

view full example data

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Colorectal Cancer	Phase 1	China	Shang Hai Xian Wei Yi Yao Ke Ji You Xian Gong Si	26 Dec 2025
Liver Cancer	Phase 1	China	Shang Hai Xian Wei Yi Yao Ke Ji You Xian Gong Si	26 Dec 2025
Non-Small Cell Lung Cancer	Phase 1	China	Shang Hai Xian Wei Yi Yao Ke Ji You Xian Gong Si	26 Dec 2025
Squamous Cell Carcinoma of Head and Neck	Phase 1	China	Shang Hai Xian Wei Yi Yao Ke Ji You Xian Gong Si	26 Dec 2025

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis